16 Results for "

Ivermectin

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "Ivermectin" in MCE Product Catalog:

50
50 Publications Verification
Cat. No.: HY-15310
CAS No.: 70288-86-7
Purity:  98.28%
Synonyms: MK-933; CD-5024; K-237
Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin (MK-933) is a specific inhibitor of Impα/β1-mediated nuclear import and has potent antiviral activity towards both HIV-1 and dengue virus. It is a positive allosteric effector of P2X4 and the α7 neuronal nicotinic acetylcholine receptor (nAChRs). Ivermectin also inhibits bovine herpesvirus1 (BoHV-1) replication and inhibits BoHV-1 DNA polymerase nuclear import . Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19 .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-17035
CAS No.: 117704-25-3
Doramectin is a derivative of Ivermectin (HY-15310). Doramectin is a potent antiparasitic antibiotic. Doramectin is an active compound against S.mansoni in an NMRI mouse infection model .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-126937
CAS No.: 71827-03-7
Purity:  99.97%
Target:  

Parasite SARS-CoV

Research Areas:  

Infection

Ivermectin B1a, a derivative of Avermectin B1a (HY-15308), is a main component of Ivermectin (HY-15310) . Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19 .
loading...
    loading...
Cat. No.: HY-W654244
Ivermectin-d2 is deuterium labeled Ivermectin .
loading...
    loading...
Cat. No.: HY-W765152
CAS No.: 2962875-16-5
Synonyms: 22,23-Dihydro avermectin B1a; epi-Dihydro avermectin B1a
Target:  

Parasite

Research Areas:  

Infection

epi-Ivermectin B1a is a key related substance of Ivermectin (HY-15310), primarily existing as a process-related impurity or potential degradation product in ivermectin-based antiparasitic formulations. epi-Ivermectin B1a can be used for the study of internal/external parasites in cattle .
loading...
    loading...
Cat. No.: HY-125729
CAS No.: 70209-81-3
Purity:  98.66%
Target:  

Parasite SARS-CoV

Research Areas:  

Infection

Ivermectin B1b is the minor component of Ivermectin. Ivermectin, a potent anti-parasitic agent, inhibits the replication of SARS-CoV-2 in cell culture .
loading...
    loading...
Cat. No.: HY-137252
CAS No.: 73162-95-5
Synonyms: Ivermectin Impurity G
Target:  

Parasite

Research Areas:  

Infection

22,23-Dihydroavermectin B1a aglycon is an acid degradation product produced by hydrolysis of the disaccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity.
loading...
    loading...
Cat. No.: HY-17035R
CAS No.: 117704-25-3
Doramectin (Standard) is the analytical standard of Doramectin. This product is intended for research and analytical applications. Doramectin is a derivative of Ivermectin (HY-15310). Doramectin is a potent antiparasitic antibiotic. Doramectin is an active compound against S.mansoni in an NMRI mouse infection model .
loading...
    loading...
Cat. No.: HY-120696
CAS No.: 1361414-26-7
Purity:  98.06%
Synonyms: ML368
Research Areas:  

Infection Cancer

SR9186 (ML368) is a selective CYP3A4 inhibitor with IC50 values of 9, 4, and 38 nM for Midazolam → 1'-hydroxymidazolam, Testosterone → 6β-hydroxytestosterone, and Vincristine → Vincristine M1, respectively. SR-9186 inhibits the development of hepatic-stage P. falciparum and blocks ivermectin metabolism. SR-9186 can be used in breast cancer research .
loading...
    loading...
Cat. No.: HY-123686
CAS No.: 71837-27-9
Target:  

Parasite

Ivermectin B1a monosaccharide is a modified Ivermectin B1a (HY-126937). Ivermectin B1a monosaccharide is an antiparasite agent with a minimum concentration for full activity in Haemonchus contortus larval development of 0.001 μg/mL .
loading...
    loading...
Cat. No.: HY-130484
CAS No.: 1135339-49-9
Target:  

Parasite

Research Areas:  

Infection

2,3-Dehydro-3,4-dihydro ivermectin is an analog of ivermectin (HY-15310) and an anthelmintic. 2,3-Dehydro-3,4-dihydro ivermectin has activity against L. amazonensis promastigotes and amastigotes (IC50s=13.8 and 3.6 µM, respectively) without inducing cytotoxicity to macrophages (IC50= 65.5 µM).
loading...
    loading...
Cat. No.: HY-147002
Purity:  ≥94.0%
Target:  

Parasite SARS-CoV

Research Areas:  

Others

7-O-Methyl Ivermectin B1a is an analogue of Ivermectin B1a (HY-126937).
loading...
    loading...
Cat. No.: HY-126937S
Ivermectin B1a-d2-1 is the deuterium labeled Ivermectin B1a (HY-126937). Ivermectin B1a, a derivative of Avermectin B1a (HY-15308), is a main component of Ivermectin (HY-15310) . Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19 .
loading...
    loading...
Cat. No.: HY-131965
CAS No.: 105828-41-9
Target:  

Drug Intermediate

Research Areas:  

Others

Imidacloprid impurity 1 (IMP-2) is the impurity found during the synthesis of Ivermectin (HY-15310) .
loading...
    loading...
Cat. No.: HY-178375S
Imidacloprid impurity 1-d4 is the deuterium labeled Imidacloprid impurity 1 (HY-131965). Imidacloprid impurity 1 (IMP-2) is the impurity found during the synthesis of Ivermectin (HY-15310) .
loading...
    loading...
Cat. No.: HY-W677714
CAS No.: 163105-64-4
Research Areas:  

Infection

SDH-IN-43 (Compound i-19) is a succinate dehydrogenase (SDH) inhibitor. SDH-IN-43 shows potent inhibitory activity against caenorhabditis elegans wirh an IC50 of 6.67 μM. SDH-IN-43 can significantly reduce caenorhabditis elegans reproductive ability and movement ability, and is also effective against drug-resistant strains of Levamisole (HY-A0106), Benzimidazole (HY-Y1825), and Ivermectin (HY-15310). SDH-IN-43 can be used for the research of parasite infection .
loading...
    loading...
  • 1